Neurological consequences of COVID-19: The ‘Silent Wave’
8 October 2020 Is the world prepared a wave of neurological consequences that may be on its way as a result of COVID-19? This question is at the forefront of research underway at the Florey Institute of Neuroscience…
WEHI researchers taking the STING out of MND
8 October 2020 Walter and Eliza Hall Institute researchers are working towards a potential treatment to slow the progression of motor neuron disease (MND), offering hope to people with this debilitating and incurable illness. The research team have…
MTPConnect release second edition of COVID-19 Impact Report
8 October 2020 Via MTPConnect With Australia confirming its first case of the coronavirus on 25 January 2020, it wasn’t long before COVID-19, the disease caused by SARS-CoV-2, emerged as a public health and economic crisis. The medical…
St Vincent’s Hospital on the Park leads new charge in Victoria’s collective fight against COVID-19
Posted 24 September 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. St Vincent’s has welcomed patients at its newest hospital to help manage the escalating demand on…
Metro Tunnel Portrait Project Showcases Faces Behind Parkville Biomedical Precinct
24 September 2020 View the full article via Metro Tunnel. The Parkville Biomedical Precinct is home to some of the world’s leading medical researchers, clinicians and academics. Through 30 Precinct Partners, it delivers outstanding clinical care and education,…
Australia’s first Antimicrobial Resistance Network forms to combat global health threat
24 September 2020 MTPConnect today announced the formation of an Australian-first network bringing together key stakeholders to address the impact of antimicrobial resistance (AMR) on human health. The Australian Antimicrobial Resistance network – AAMRNet – has been established…
The Florey partners in multi-institute Mental Health PhD Program
Date posted 22 September 2020 The Florey Institute of Neuroscience and Mental Health will share responsibility for shaping and steering the University of Melbourne’s Mental Health PhD program with the Centre for Mental Health, the Department of Psychiatry,…
CSIRO identifies opportunities for economic recovery
Date posted 22 September 2020 Release date 16 September 2020 A new report from Australia’s national science agency, CSIRO, has revealed the opportunities for key industries to leverage science and technology and help restore economic growth and resilience.…
Bosch virtual companion increases safety for trucks on the road
Date posted 22 September 2020 Release date 18 September 2020 Research project to develop attention and activity assistant for automated driving Break up the monotony of the drive, maintain alertness, avoid accidents. Ensure perfect interaction between truck and…
Noxopharm Appoints US Corporate Advisory and Consulting Firm
Date posted 22 September 2020 Release date 18 September 2020 Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) is pleased to announce that it has appointed US corporate advisory and consulting firm, Destum Partners, to advise on…
Immutep Reports Improving Results from INSIGHT-004 Trial
Date posted 22 September 2020 Release date 18 September 2020 41.7% of patients showed a Partial Response to the combination therapy of eftilagimod alpha and avelumab (previously 33%) Encouraging early anti-tumour activity signals in a variety of cancer…
Immutep Announces Improving Results from Stage I of Phase II TACTI-002 Study
Date posted 22 September 2020 Release date 18 September 2020 Three complete responses (complete disappearance of all lesions) reported: two in 2nd line head and neck squamous cell carcinoma (HNSCC) and one in 1st line non-small cell lung…
